Stem Cell Advance Yields Over 140 Cell Types From Human Embryonic Stem Cells

A team of North American scientists has unveiled a new technology that could revolutionize the industrialization and commercialization of stem cell therapies. Since the first isolation of human embryonic stem cells in 1998, researchers have struggled to find a means to isolate purified populations of the many hundreds of medically-relevant cell types. Scalability has therefore been a major barrier for development of therapies on a population scale.

More: continued here

Filed under: Genetics on April 4th, 2008